PharmaSGP Holding SE

XTRA:PSG Stock Report

Market Cap: €302.2m

PharmaSGP Holding Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Natalie Weigand

Chief executive officer

€865.0k

Total compensation

CEO salary percentage34.7%
CEO tenure4.7yrs
CEO ownershipn/a
Management average tenure4.7yrs
Board average tenure4.7yrs

Recent management updates

Recent updates

Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

May 06
Shareholders Will Be Pleased With The Quality of PharmaSGP Holding's (ETR:PSG) Earnings

Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio

Mar 02
Some Shareholders Feeling Restless Over PharmaSGP Holding SE's (ETR:PSG) P/E Ratio

PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

Dec 02
PharmaSGP Holding SE Just Beat Revenue Estimates By 25%

One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

Feb 16
One Analyst Just Shaved Their PharmaSGP Holding SE (ETR:PSG) Forecasts Dramatically

We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Jan 26
We Think PharmaSGP Holding's (ETR:PSG) Statutory Profit Might Understate Its Earnings Potential

Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

Dec 04
Do Institutions Own PharmaSGP Holding SE (ETR:PSG) Shares?

CEO Compensation Analysis

How has Natalie Weigand's remuneration changed compared to PharmaSGP Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

€18m

Mar 31 2024n/an/a

€18m

Dec 31 2023€865k€300k

€16m

Sep 30 2023n/an/a

€15m

Jun 30 2023n/an/a

€14m

Mar 31 2023n/an/a

€13m

Dec 31 2022€314k€250k

€12m

Sep 30 2022n/an/a

€11m

Jun 30 2022n/an/a

€11m

Mar 31 2022n/an/a

€11m

Dec 31 2021€272k€250k

€11m

Sep 30 2021n/an/a

€8m

Jun 30 2021n/an/a

€8m

Mar 31 2021n/an/a

€9m

Dec 31 2020€279k€258k

€11m

Sep 30 2020n/an/a

€16m

Jun 30 2020n/an/a

€17m

Mar 31 2020n/an/a

€17m

Dec 31 2019€141k€141k

€17m

Compensation vs Market: Natalie's total compensation ($USD909.38K) is about average for companies of similar size in the German market ($USD1.06M).

Compensation vs Earnings: Natalie's compensation has increased by more than 20% in the past year.

CEO

Natalie Weigand (43 yo)

4.7yrs

Tenure

€865,000

Compensation

Ms. Natalie Weigand serves as the Chief Executive Officer at PharmaSGP Holding SE since June 2020 and also serves as a Member of Management Board since March 04, 2020. She joined the FUTRUE Group as the le...

Leadership Team

NamePositionTenureCompensationOwnership
Natalie Weigand
CEO & Member of Management Board4.7yrs€865.00kno data
Michael Rudolf
CFO & Member of Management Board4.7yrs€879.00kno data
Peter Gerckens
Member of Management Boardless than a yearno datano data

4.7yrs

Average Tenure

Experienced Management: PSG's management team is considered experienced (4.7 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Axel Rebien
Member of the Supervisory Board4.4yrs€50.00kno data
Madlena Hohlefelder
Deputy Chairwoman of the Supervisory Board4.7yrsno data48.95%
€ 147.9m
Clemens Fischer
Chairman of the Supervisory Board4.7yrsno datano data

4.7yrs

Average Tenure

49yo

Average Age

Experienced Board: PSG's board of directors are considered experienced (4.7 years average tenure).